Skip to content

Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy

Thulium Beam Coagulation Versus Suture Renorrhaphy for Hemostasis of Tumor Bed in Laparoscopic Partial Nephrectomy: Prospective Randomized Comparative Study

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06322745
Enrollment
30
Registered
2024-03-21
Start date
2023-06-01
Completion date
2025-03-01
Last updated
2024-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Renal Malignant Tumor, Renal Tumor

Keywords

Thulium laser, Laparoscopic partial nephrectomy, Ischemia time, Small renal mass

Brief summary

To compare the outcome of thulium beam coagulation versus suture renorrhaphy for hemostasis of the tumor bed in laparoscopic partial nephrectomy.

Detailed description

To date, no studies have compared the outcomes of thulium beam coagulation versus suture renorrhaphy for hemostasis of tumor bed in laparoscopic partial nephrectomy in patients with small renal messes (SRMs). This study aims to compare the outcome of thulium beam coagulation versus suture renorrhaphy for hemostasis of the tumor bed in laparoscopic partial nephrectomy. The investigators hypothesize that: Conducted well designed, randomized prospective comparative study can help to identify which technique is better. Using thulium beam coagulation for hemostasis of the tumor bed in laparoscopic partial nephrectomy can improve the outcome, shorten intraoperative ischemia time and decrease blood loss.

Interventions

PROCEDURESuture renorrhaphy only for hemostasis of the tumor bed in laparoscopic partial nephrectomy

Suture renorrhaphy will be used in 2 layers; medullary and cortical, with Vicry 2/0 or 3/0 and secured with V-lock. Early unclamping will be done after hemostasis of the medullary layer. Renorrhaphy of the cortical layer will be continued after that.

PROCEDUREThulium beam coagulation and suture renorrhaphy for hemostasis of the tumor bed in laparoscopic partial nephrectomy

A 2-μm continuous thulium laser with 365 μm laser fiber at 30-40 W will be used for coagulation of the tumor bed. Large vessels that may not be completely sealed with thulium beam will be closed by V-lock to achieve safe and stable hemostasis. Early unclamping will be done after hemostasis of the tumor bed. Suture renorrhaphy will be used in 1 layer to approximate the renal parenchyma.

Sponsors

Al-Azhar University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

A randomized prospective comparative study. Two-arm parallel assignment: First Arm: involves cases of laparoscopic partial nephrectomy done with suture renorrhaphy only for hemostasis of the tumor bed. Second Arm: involves cases of laparoscopic partial nephrectomy using thulium beam coagulation and suture renorrhaphy for hemostasis of the tumor bed.

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* cT1 single renal mass.

Exclusion criteria

1. Absolute contraindication for laparoscopic surgery (e.g., severe cardiopulmonary insufficiency, and chronic obstructive lung disease). 2. Renal mass involving the hilum. 3. Renal mass in patients with chronic kidney disease.

Design outcomes

Primary

MeasureTime frameDescription
Monocyte chemoattractant protein (MCP-1) urine levelpre-surgery, at 24 hours and at 1 monthwill be measured in urine to indicate the fibrogenic process that occurs in renal parenchyma after PN
Renal function: estimated GFR (eGFR)3 monthsill be estimated by estimated GFR (eGFR) using Modification of Diet in Renal Disease (MDRD) equation (Levey et al., 2006). Chronic kidney disease (CKD): will be staged according to Kidney Disease Improving Global Outcomes (KDIGO) guidelines to reflect the change of renal function
Transforming growth factor beta (TGF-β) urine levelpre-surgery, at 24 hours and at 1 monthwill be measured in urine to indicate the fibrogenic process that occurs in renal parenchyma after PN
Intraoperative Blood lossduring the surgeryBlood loss will be calculated from the suction jar minus the amount of fluid irrigation
Blood transfusion rateperioperativelyAmount of blood in ml transfused intraoperative or postoperative
Intraoperative number of sutures for renorraphyduring the surgerywhich is the count of each time the needle comes out from the renal parenchyma.
Suture time and operative time in minutesduring the surgerySuture time starts from the first suture to the last one, including time of manipulating needles.
Intraoperative Warm Ischemia time (WIT) in minutes (time of renal artery clamping).during the surgeryStarted once renal artery clamped before tumor enucleation till release of the clamp after 1st layer renorraphy in group 1 or Thulium beam coagulation in group 2
Renal function: serum creatinine3 monthswill be estimated by serum creatinine. Chronic kidney disease (CKD): will be staged according to Kidney Disease Improving Global Outcomes (KDIGO) guidelines to reflect the change of renal function

Secondary

MeasureTime frameDescription
Post operative painperioperativelyby Visual Analogue Scale The visual analog scale (VAS) is a validated, subjective measure for acute and chronic pain. Scores are recorded by making a handwritten mark on a 100 mm line that represents a continuum between 0 or no pain and 100 or worst pain.
Hospital stayperioperativelyfrom time of surgery till time of patient discharge.

Countries

Egypt

Contacts

Primary ContactEhab Atallah, A. Lecturer
Ehab44ehab@gmail.com00201009661125
Backup ContactHesham AboZied, Professor
urologydepartment@azhar.edu.eg00201062087567

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026